ILX651

· Genzyme, a Sanofi Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ILX651, covering 2015-03-05 to 2015-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel [Phase 2]